Study evaluates two multiplex real-time PCR assays for simultaneous detection of MPVX

→ Bio­gen chief med­ical of­fi­cer Ma­ha Rad­hakr­ish­nan is out af­ter four years “as of March 1,” a spokesper­son tells Peer Re­view. Bio­gen didn’t draw up

Dan­tari’s drug con­ju­gate as­set has pro­duced pos­i­tive da­ta as both a monother­a­py and in com­bi­na­tion with a PARP in­hibitor in an ear­ly-stage breast can­cer tri­al,